These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21151800)

  • 21. Human T cell clones allospecific for HLA-DR5 antigen with the OKT8 phenotype.
    Chardonnens X; Froment Y; Morgan G; Jeannet M
    Tissue Antigens; 1983 Jul; 22(1):76-81. PubMed ID: 6193608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial class II antigen expression in cutaneous graft-versus-host disease.
    Beschorner WE; Farmer ER; Saral R; Stirling WL; Santos GW
    Transplantation; 1987 Aug; 44(2):237-43. PubMed ID: 3307048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
    Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
    Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A "new" primed lymphocyte typing (PLT) defined DP-antigen associated with a private HLA--DR antigen.
    Morling N; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Tissue Antigens; 1980 Jul; 16(1):95-104. PubMed ID: 6162231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro studies of endomyocardial biopsies from heart transplant recipients on RATG and OKT3 immunoprophylaxis protocols.
    Kaufman C; Zeevi A; Zerbe T; Kormos R; Griffith B; Hardesty R; Duquesnoy RJ
    Transplantation; 1989 Oct; 48(4):621-5. PubMed ID: 2799915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection?
    Reinsmoen NL; Bolman RM; Savik K; Butters K; Hertz MI
    Transplantation; 1993 May; 55(5):1040-4. PubMed ID: 7684535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alloreactive lymphoid infiltrates in human heart transplants. Loss of class II-directed cytotoxicity more than 3 months after transplantation.
    Ouwehand AJ; Vaessen LM; Baan CC; Jutte NH; Balk AH; Essed CE; Bos E; Claas FH; Weimar W
    Hum Immunol; 1991 Jan; 30(1):50-9. PubMed ID: 1900500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Typing for HLA-D/DR associated DP-antigens with the primed lymphocyte typing (PLT) technique.
    Morling N; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Tissue Antigens; 1980 May; 15(5):471-82. PubMed ID: 6449760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of the role of professional versus semiprofessional or nonprofessional antigen presenting cells in the rejection of vascularized organ allografts.
    Sundstrom JB; Ansari AA
    Transpl Immunol; 1995 Dec; 3(4):273-89. PubMed ID: 8665146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the expression of major histocompatibility complex class II antigens in liver allograft rejection.
    Hubscher SG; Adams DH; Elias E
    J Pathol; 1990 Oct; 162(2):165-71. PubMed ID: 2250195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II.
    van Balen P; van Bergen CAM; van Luxemburg-Heijs SAP; de Klerk W; van Egmond EHM; Veld SAJ; Halkes CJM; Zwaginga JJ; Griffioen M; Jedema I; Falkenburg JHF
    Front Immunol; 2018; 9():3016. PubMed ID: 30619360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of human cardiac infiltrating cells posttransplantation: II. CD4+ cloned T-cell lines with "anti-idiotype"-like reactivity.
    Wang YC; Kanter K; Lattouf O; Rodey GE; Sell KW; Ansari AA
    Hum Immunol; 1990 Jun; 28(2):141-52. PubMed ID: 1972150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Function of alloproliferative T lymphocyte clones correlates better with their class II recognitive specificity than with their cell surface phenotype.
    Pawelec G; Schneider EM; Wernet P
    Eur J Immunol; 1985 Feb; 15(2):163-7. PubMed ID: 3871698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
    Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
    Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between HLA-D/DR associated primed lymphocyte typing (PLT) defined DP-antigens, HLA-D and HLA-DR antigens.
    Morling N; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Tissue Antigens; 1981; 17(4):421-7. PubMed ID: 7036403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenetic analysis of the HLA complex with alloreactive T cell clones.
    Duquesnoy RJ; Zeevi A
    Hum Immunol; 1983 Sep; 8(1):17-23. PubMed ID: 6226628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precise specificity of induced tubular HLA-class II antigens in renal allografts.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transplantation; 1987 Aug; 44(2):214-20. PubMed ID: 3307044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human allograft-derived T-cell lines: donor class I- and class II-directed cytotoxicity and repertoire stability in sequential biopsies.
    Miceli MC; Barry TS; Finn OJ
    Hum Immunol; 1988 Jul; 22(3):185-98. PubMed ID: 3139590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PIRCHE-II scores prove useful as a predictive biomarker among kidney transplant recipients with rejection: An analysis of indication and follow-up biopsies.
    Spitznagel T; Matter LS; Kaufmann YL; Nilsson J; von Moos S; Schachtner T
    Front Immunol; 2022; 13():949933. PubMed ID: 36059499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.